CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 415 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02194439
NCT02194439N/ACompleted
CompareCT.gov

Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease

Indiana University·observational·Posted Jul 18, 2014·Updated Feb 26, 2021

In Brief

An observational study for Graft-Versus-Host Disease. Completed, enrolled 415 participants across 1 site.

Detailed Summary

This study is designed to collect longitudinal biological samples from patients after hematopoietic cell transplantation (HCT) cared for at multiple bone marrow transplant centers to validate biomarkers of both acute and chronic GVHD as well as for use in future unspecified research. The centers include Dana-Farber Cancer Institute and Boston's Children's Hospital, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Fred Hutchinson Cancer Research Center, Texas Children's Hospital, Children's National Medical Center, and Indiana University Simon Cancer Center.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGraft-Versus-Host Disease
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 18, 2014
Enrollment StartJan 1, 2014
Primary CompletionSep 30, 2019
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 12.0 years ago